HY-106662-5mg
|
MedChemexpress LLC
|
Chloroquinoxaline sulfonamide [CAS 97919-22-7]
|
|
Cancer-programmed cell death
|
|
HY-106662-50mg
|
MedChemexpress LLC
|
Chloroquinoxaline sulfonamide [CAS 97919-22-7]
|
|
Cancer-programmed cell death
|
|
HY-106961A-1mg
|
MedChemexpress LLC
|
(Z)-ONO 1301 [CAS 153814-74-5]
|
|
|
|
HY-106961A-5mg
|
MedChemexpress LLC
|
(Z)-ONO 1301 [CAS 153814-74-5]
|
|
|
|
HY-107477-1mg
|
MedChemexpress LLC
|
GSK8573 [CAS 1693766-04-9]
|
|
Cancer-programmed cell death
|
|
HY-107477-10mg
|
MedChemexpress LLC
|
GSK8573 [CAS 1693766-04-9]
|
|
Cancer-programmed cell death
|
|
HY-107477-100mg
|
MedChemexpress LLC
|
GSK8573 [CAS 1693766-04-9]
|
|
Cancer-programmed cell death
|
|
HY-107477-25mg
|
MedChemexpress LLC
|
GSK8573 [CAS 1693766-04-9]
|
|
Cancer-programmed cell death
|
|
HY-107477-5mg
|
MedChemexpress LLC
|
GSK8573 [CAS 1693766-04-9]
|
|
Cancer-programmed cell death
|
|
HY-107477-50mg
|
MedChemexpress LLC
|
GSK8573 [CAS 1693766-04-9]
|
|
Cancer-programmed cell death
|
|
HY-107771-10mg
|
MedChemexpress LLC
|
Fluensulfone [CAS 318290-98-1]
|
|
Cancer-programmed cell death
|
|
HY-107771-2mg
|
MedChemexpress LLC
|
Fluensulfone [CAS 318290-98-1]
|
|
Cancer-programmed cell death
|
|
HY-107771-25mg
|
MedChemexpress LLC
|
Fluensulfone [CAS 318290-98-1]
|
|
Cancer-programmed cell death
|
|
HY-107771-5mg
|
MedChemexpress LLC
|
Fluensulfone [CAS 318290-98-1]
|
|
Cancer-programmed cell death
|
|
HY-109030-10mg
|
MedChemexpress LLC
|
Dorzagliatin [CAS 1191995-00-2]
|
|
Metabolism-sugar/lipid metabolism
|
|
HY-109030-100mg
|
MedChemexpress LLC
|
Dorzagliatin [CAS 1191995-00-2]
|
|
Metabolism-sugar/lipid metabolism
|
|
HY-109030-25mg
|
MedChemexpress LLC
|
Dorzagliatin [CAS 1191995-00-2]
|
|
Metabolism-sugar/lipid metabolism
|
|
HY-109030-5mg
|
MedChemexpress LLC
|
Dorzagliatin [CAS 1191995-00-2]
|
|
Metabolism-sugar/lipid metabolism
|
|
HY-109030-50mg
|
MedChemexpress LLC
|
Dorzagliatin [CAS 1191995-00-2]
|
|
Metabolism-sugar/lipid metabolism
|
|
HY-110258B-10mg
|
MedChemexpress LLC
|
(R,S,R)-ML334 [CAS 1432065-33-2]
|
|
|
|
HY-110258B-100mg
|
MedChemexpress LLC
|
(R,S,R)-ML334 [CAS 1432065-33-2]
|
|
|
|
HY-110258B-25mg
|
MedChemexpress LLC
|
(R,S,R)-ML334 [CAS 1432065-33-2]
|
|
|
|
HY-110258B-5mg
|
MedChemexpress LLC
|
(R,S,R)-ML334 [CAS 1432065-33-2]
|
|
|
|
HY-110258B-50mg
|
MedChemexpress LLC
|
(R,S,R)-ML334 [CAS 1432065-33-2]
|
|
|
|
HY-111457-10mg
|
MedChemexpress LLC
|
BAY-677 [CAS 2117404-84-7]
|
|
Neuroscience-Neuromodulation
|
|